MyLimus contains Sirolimus, an immunosuppressant medication primarily used to prevent organ transplant rejection. It helps the body accept transplanted organs by reducing the activity of the immune system.

Mechanism of action:
Sirolimus works by inhibiting the mTOR (mechanistic target of rapamycin) pathway, which is crucial for T-cell activation and proliferation. By suppressing T-cell activity, MyLimus prevents the immune system from attacking the transplanted organ.

Uses:

• Prevention of kidney transplant rejection

• Occasionally used for other organ transplants

• Sometimes prescribed for certain rare immune-related conditions

Adverse effects:
Common side effects include increased cholesterol and triglycerides, swelling, headache, diarrhea, and mild fatigue. Rare but serious effects may include infections due to immune suppression, delayed wound healing, kidney problems, or lung toxicity. Regular blood tests are required to monitor drug levels, kidney function, and blood counts.